Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 4/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Unknown
Symptoms: Amnesia, Depression, Muscular weakness, Pain, Post viral fatigue syndrome
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: Acetaminophen (+) codeine phosphate; ibuprofen lysine; pizotyline
Diagnostic Lab Data:
CDC 'Split Type': GB0095075131612GBR012907
Write-up:Information has been received from a consumer via agency (HA# GB-MHRA-EYC 00150655) concerning a 12 year old male patient. The concurrent condition and medical history were not reported. Concomitant therapies included acetaminophen (+) codeine phosphate, ibuprofen lysine and pizotyline. On an unknown date, the patient was vaccinated with a dose of human papillomavirus vaccine (manufacturer unknown) (lot#, expiry date, strength and dose were unspecified) parenterally for prophylaxis. On unknown dates, the patient had experienced myalgic encephalomyelitis, chronic pain, memory loss, muscle weakness and depression. It was reported that the patient should not have been dispensed in school. The advices of lots of specialist had been sought. The outcome of those events was not resolved. The causality assessment between the unspecified therapy (Active Drug substance name: human papilloma virus) and events was not provided. The events were considered to be disabling and medically significant.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166